
Search
Filter Results
Displaying 231–240 of 1069 results
-
Sep 29, 2023
Eye on the Cure Podcast | Episode 54: Rachelle Lin, OD, MS, FAAO
Rachelle Lin, OD, MS, FAAO, an optometrist and assistant professor at the Southern California College of Optometry at Marshall B. Ketchum University, talks with host Ben Shaberman about the critical role of optometrists in providing care and low-vision resources for patients with inherited retinal diseases and other eye conditions.
-
-
Sep 18, 2023
How an Assistive App Developer is Revolutionizing Accessibility
Meet Rebecca Rosenberg, the founder of ReBokeh Vision Technologies, whose journey from engineer to entrepreneur may have been guided by fate. Diagnosed with oculocutaneous albinism (OCA1) at a young age, Rebecca faced numerous obstacles due to the lack of assistive technology tailored to her unique needs. This inspired her to create an app that would revolutionize the world of assistive technology for those with moderate low vision.
-
Sep 18, 2023
Ocugen Reports Updated Results for Clinical Trial of Modifier Gene Therapy
The company is also launching modifier gene therapy clinical trials for GA and Stargardt disease
-
Sep 15, 2023
Eye on the Cure Podcast | Episode 53: David Birch, PhD
David Birch, PhD, at the Retina Foundation of the Southwest in Dallas, talks to host Ben Shaberman about his productive and impactful 40-plus-year career as a retinal disease researcher and clinical trial investigator. Dr. Birch also discusses the challenges and opportunities for advancing more therapies through trials and out to the people who need them.
-
The CRB1 Landscape Document provides an overview of Crumbs homolog-1/CRB1 at multiple levels: the gene, the protein, its function, and the epidemiology and clinical manifestations of CRB1-associated disease, as well as potential treatment strategies, with a focus on the retina.
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2023 (July 1, 2022–June 30, 2023)
-
Sep 7, 2023
First Patient Dosed in LCA5 Gene Therapy Clinical Trial Launched by Opus Genetics
Opus was established by the RD Fund, the Foundation’s venture philanthropy arm
-
Sep 7, 2023
Foundation Funds 25 New Grants Totaling $15.1 Million in FY23
The global leader in retinal degenerative disease research supports a total of 93 research grants in its portfolio.
-
Sep 6, 2023
Therapeutic Targets for Dry AMD: A Foundation Fighting Blindness Webinar for Eye Care Professionals
The free, online event will feature a lecture from David Boyer, MD, a Senior Partner at Retina-Vitreous Associates Medical Group and dry AMD expert.